Pharming Group N.V.
- Last sale
- Nov 9, 2026 · +7.09%
- Market cap
- $922.01M
- 70.17M shares
- Filings
- 149
FY 2025+26.6% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025+164.5% FY25 yoy
- $922.01M
- 323.4×
- 2.5×
- 3.3×
- 5.85%
- —
FY2025 figures · derived
Price
Nov 9, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $376,134,000 | reported | |
| FY 2024 | 2024-12-31 | $297,200,000 | reported | |
| FY 2023 | 2023-12-31 | $245,316,000 | reported | |
| FY 2022 | 2022-12-31 | $205,622,000 | reported | |
| FY 2021 | 2021-12-31 | $198,871,000 | reported | |
| FY 2020 | 2020-12-31 | $212,174,000 | reported | |
| FY 2019 | 2019-12-31 | $189,389,000 | reported |
Segments
LineFY2022ShareChange
U.S.-$670.00K—N/M
NETHERLANDS-$13.56M—N/M
France———
Total$18.23M
Pharmaceutical preparations
Pharming Group N.V. is the 63rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ZLABZai Lab Ltd$460.2M15.3%38.1%$29.3BARWRArrowhead Pharmaceuticals, Inc.$450.8M45.6%160.6%$6.7BINVAInnoviva, Inc.$411.3M14.7%65.9%$1.3BARDXArdelyx, Inc.$407.3M22.1%15.1%$781.8MSVASinovac Biotech Ltd$386.0M6.8%51.5%$464.9M
PHARPharming Group N.V. (this company)$376.1M26.6%0.8%$922.0M
ARQTArcutis Biotherapeutics, Inc.$376.1M91.3%4.3%$3.3BMNKDMannkind Corp$349.0M22.2%1.7%$1.3BCRMDCorMedix Inc.$311.7M617.0%52.3%$427.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Pharming Group N.V. · CIK 1828316 · Engraved from SEC EDGAR